Literature DB >> 30385008

The Salt-Inducible Kinases: Emerging Metabolic Regulators.

Kei Sakamoto1, Laurent Bultot2, Olga Göransson3.   

Abstract

The discovery of liver kinase B1 (LKB1) as an upstream kinase for AMP-activated protein kinase (AMPK) led to the identification of several related kinases that also rely on LKB1 for their catalytic activity. Among these, the salt-inducible kinases (SIKs) have emerged as key regulators of metabolism. Unlike AMPK, SIKs do not respond to nucleotides, but their function is regulated by extracellular signals, such as hormones, through complex LKB1-independent mechanisms. While AMPK acts on multiple targets, including metabolic enzymes, to maintain cellular ATP levels, SIKs primarily regulate gene expression, by acting on transcriptional regulators, such as the cAMP response element-binding protein-regulated transcription coactivators and class IIa histone deacetylases. This review describes the development of research on SIKs, from their discovery to the most recent findings on metabolic regulation.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  AMP-activated protein kinase; AMPK; AMPK-related kinase; LKB1; energy metabolism; gluconeogenesis

Mesh:

Substances:

Year:  2018        PMID: 30385008     DOI: 10.1016/j.tem.2018.09.007

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  25 in total

1.  Salt-inducible Kinases Are Critical Determinants of Female Fertility.

Authors:  Marah Armouti; Nicola Winston; Osamu Hatano; Elie Hobeika; Jennifer Hirshfeld-Cytron; Juergen Liebermann; Hiroshi Takemori; Carlos Stocco
Journal:  Endocrinology       Date:  2020-07-01       Impact factor: 4.736

2.  A salt-induced kinase is required for the metabolic regulation of sleep.

Authors:  Jeremy J Grubbs; Lindsey E Lopes; Alexander M van der Linden; David M Raizen
Journal:  PLoS Biol       Date:  2020-04-21       Impact factor: 8.029

3.  Salt-inducible kinases dictate parathyroid hormone 1 receptor action in bone development and remodeling.

Authors:  Shigeki Nishimori; Maureen J O'Meara; Christian D Castro; Hiroshi Noda; Murat Cetinbas; Janaina da Silva Martins; Ugur Ayturk; Daniel J Brooks; Michael Bruce; Mizuki Nagata; Wanida Ono; Christopher J Janton; Mary L Bouxsein; Marc Foretz; Rebecca Berdeaux; Ruslan I Sadreyev; Thomas J Gardella; Harald Jüppner; Henry M Kronenberg; Marc N Wein
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

4.  Designing of potent anti-diabetic molecules by targeting SIK2 using computational approaches.

Authors:  Prajisha Jayaprakash; Jayashree Biswal; Raghu Rangaswamy; Jeyaraman Jeyakanthan
Journal:  Mol Divers       Date:  2022-06-21       Impact factor: 2.943

5.  Novel mutation of SIK1 gene causing a mild form of pediatric epilepsy in a Chinese patient.

Authors:  Wangshu Xu; Wenqun Zhang; Lili Cui; Lei Shi; Bin Zhu; Tina-Jie Lyu; Wenping Ma
Journal:  Metab Brain Dis       Date:  2022-03-10       Impact factor: 3.584

6.  SIK2 orchestrates actin-dependent host response upon Salmonella infection.

Authors:  Marcel Hahn; Adriana Covarrubias-Pinto; Lina Herhaus; Shankha Satpathy; Kevin Klann; Keith B Boyle; Christian Münch; Krishnaraj Rajalingam; Felix Randow; Chunaram Choudhary; Ivan Dikic
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-11       Impact factor: 11.205

7.  In vivo screen identifies a SIK inhibitor that induces β cell proliferation through a transient UPR.

Authors:  Lipeng Ren; Rohit B Sharma; Jérémie Charbord; Anna Johansson; Rasmus Ågren; Lianhe Chu; Dominika Tworus; Nadja Schulz; Pierre Charbord; Andrew F Stewart; Peng Wang; Laura C Alonso; Olov Andersson
Journal:  Nat Metab       Date:  2021-05-20

8.  Dasatinib-SIK2 Binding Elucidated by Homology Modeling, Molecular Docking, and Dynamics Simulations.

Authors:  Mingsong Shi; Lun Wang; Penghui Li; Jiang Liu; Lijuan Chen; Dingguo Xu
Journal:  ACS Omega       Date:  2021-04-15

9.  Comparable Initial Engagement of Intracellular Signaling Pathways by Parathyroid Hormone Receptor Ligands Teriparatide, Abaloparatide, and Long-Acting PTH.

Authors:  Tadatoshi Sato; Shiv Verma; Ashok Khatri; Thomas Dean; Olga Goransson; Thomas J Gardella; Marc N Wein
Journal:  JBMR Plus       Date:  2021-05-06

10.  Liver kinase B1 depletion from astrocytes worsens disease in a mouse model of multiple sclerosis.

Authors:  Sergey Kalinin; Gordon P Meares; Shao Xia Lin; Elizabeth A Pietruczyk; Gesine Saher; Lena Spieth; Klaus-Armin Nave; Anne I Boullerne; Sarah E Lutz; Etty N Benveniste; Douglas L Feinstein
Journal:  Glia       Date:  2019-10-30       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.